Targeted TreatmentTargeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Sponsor:

Alliance for Clinical Trials in Oncology

Code:

NCT06632977

Conditions

Castration-Resistant Prostate Carcinoma

Stage IVB Prostate Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Genetic testing

Valemetostat Tosylate

Magnetic Resonance Imaging

Computed Tomography

Bone scan

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-21. This information was provided to ClinicalTrials.gov by Alliance for Clinical Trials in Oncology on 2026-08-05.